Cheryl Gault - 03 Mar 2025 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role
Chief Operating Officer
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol
RAPP
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
05 Mar 2025, 17:00:09 UTC
Previous filing
04 Feb 2025
Next filing
10 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAPP Common Stock Award $0 +13,987 +8.9% $0.000000 171,928 03 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2024 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in two equal annual installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.